Highlights
NASDAQ: URGN       Urogen Pharma Ltd
Last Price Today's Change   Day's Range   Trading Volume
32.36   -1.03 (3.08%)  31.94 - 33.69  119,400

Overview

 
Avg Volume (4 weeks):176,189
4 Weeks Range:26.06 - 35.00
4 Weeks Price Volatility (%):
70.47%
52 Weeks Range:20.72 - 55.49
52 Weeks Price Volatility (%):
33.48%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. It has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. The company's lead product candidates, MitoGel and VesiGel, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers